Meyka Pro banner
PerkinElmer, Inc.

PerkinElmer, Inc. (PKI) Stock Overview

Explore PerkinElmer, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PKINYSE
HealthcareMedical - Diagnostics & Research
$115.24
$1.06(0.91%)
U.S. Market opens in 13h 59m

PerkinElmer, Inc. (PKI)

Meyka AI Score

Z

Key Financials

Market Cap14.5B
P/E Ratio54.88
EPS (TTM)$2.78
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$7.17

PKI Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of PerkinElmer, Inc. (NYSE: PKI) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, PerkinElmer, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PKI on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $7.17 for the NYSE listing.

Key metrics behind PerkinElmer, Inc.'s NYSE-traded stock include a P/E ratio of 54.88 and a market capitalization of 14.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PKI on the NYSE.

Price Performance (NYSE: PKI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.91%
3-Month Change
-6.55%
6-Month Change
-19.81%
Year-to-Date (YTD) Change
-18.35%
1-Year Change
-16.58%
3-Year Change
17.27%
5-Year Change
47.10%
All-Time (Max) Change
8140.26%

Contact Information

781 663 6900
940 Winter Street, Waltham, MA, 02451

Company Facts

167,000 Employees
IPO DateApr 6, 1983
CountryUS

Frequently Asked Questions